Table 1.
Authors | Interventions | Sample Size | Relative Risk Reduction of Pain WOMAC |
---|---|---|---|
Laufer et al., (2005) [41] | H-PSWD | n (H-PSWD) = 32 | 9% |
L-PSWD | n (L-PSWD) = 38 | 3% | |
Giombini et al., (2011) [40] | MD | n (MD) = 30 | 44% |
Rattanachaiyanont et al., (2008) [42] | SWD | n (SWD) = 50 | 27% |
Rabini et al., (2012) [39] | SHT | n (SHT) = 27 | 8% |
DHT | n (DHT) = 27 | 45% | |
Ozen et al., (2019) [43] | CSWD | n (CSWD) = 14 | 26% |
PSWD | n(PSWD) = 20 | 23% | |
Boyaci et al., (2013) [38] | SWD | n (SWD) = 35 | 22% |
Sarifakioglu et al., (2014) [37] | SWD | n (SWD) = 63 | 39% |